Latest in Fda's Approval Non
Sort by
19 items
-
FDA’s Food Safety Chief Resigns
The chief said the loss of critical employees overseeing the nation’s food supply made his work impossible. Robert F. Kennedy Jr., the nation’s new health secretary, has pledged to gut the division.The New York Times - 3d -
Niger junta to consider proposal for 5-year transition to non-military rule
Niger’s National Conference has submitted a proposal to return the country to non-military rule after a five-year transition period during which the current military government will stay in powerABC News - 1d -
FDA declares end to Wegovy and Ozempic shortage
The agency first declared a shortage of semaglutide, the main ingredient used to make Ozempic and Wegovy, in 2022.CBS News - 11h -
Court Approves $795 Million Debt Deal for Spirit Airlines
A U.S. Bankruptcy Judge approved the Spirit Airlines’ restructuring proposal.Inc. - 23h -
Senate Republicans approve budget framework, pushing past Democratic objections
Republican senators pushed a $340 billion budget framework to passage over Democratic objections after a nearly all-night voteABC News - 17h -
Meta approves plan for bigger executive bonuses following 5% layoffs
Meta's executive officers could earn a bonus of 200% of their base salary under the company's new executive bonus plan, up from the 75% they earned previously.CNBC - 14h -
Meta approves plan for bigger executive bonuses following 5% layoffs
Executives at Meta stand to get bigger bonuses this year.NBC News - 12h -
Airbus could prioritize deliveries to non-U.S. customers if Trump tariffs impede trade, CEO says
Guillaume Faury also said Airbus had ramped up U.S. production in recent years and that he hoped tariffs would not disrupt the aviation industry.CNBC - 1d -
Airbus could prioritize deliveries to non-U.S. customers if Trump tariffs impede trade, CEO says
Airbus could prioritize deliveries to its non-U.S.NBC News - 1d -
Brazil's top court justice orders X to pay $1.4 million fine for non-compliance
Brazil’s Supreme Court Justice Alexandre de Moraes has ordered X to pay 8.1 million Brazilian reais ($1.4 million) in fines for failing to comply with judicial ordersABC News - 1d -
Top FDA official resigns, warns firings will backfire on RFK Jr.
James Jones resigned as FDA deputy commissioner and said the Trump administration's "indiscriminate" job cuts show "disdain for the very people necessary to implement your agenda."CBS News - 1d -
FDA says Ozempic and Wegovy shortage is ending. That’s bad news for this wellness stock.
“We will continue to offer access to personalized treatments as allowed by law to meet patient needs,” Hims & Hers CEO said.MarketWatch - 9h -
Ozempic and Wegovy officially moved off FDA's drug shortage list
Ozempic and Wegovy, the widely popular forms of semaglutide sold to treat diabetes and obesity, have officially been removed from the Food and Drug Administration's (FDA) drug shortage list nearly ...The Hill - 6h -
Shortage of Novo Nordisk's Wegovy and Ozempic drugs is resolved, FDA says
The FDA's decision will threaten the ability of compounding pharmacies to make far cheaper, unbranded versions of the injections over the next few months.CNBC - 6h -
EU envoys approve more sanctions against Russia to mark the third anniversary of its war on Ukraine
European Union envoys have approved new sanctions against Russia, with the measures set to enter into force next week on the third anniversary of its full-scale invasion of UkraineABC News - 2d -
-
Meta Approves Executive Bonuses Up to 200 Percent After Laying Off 1 in 20 Workers
Your company should consider the message this sends to the non-executive workforce, and not follow the tech giant’s example.Inc. - 9h -
Firings at FDA Decimated Teams for AI and Food Safety. Those Hires Are Now Gone.
Teams evaluating high-tech surgical robots and insulin-delivery systems were gutted by Trump layoffs even though industry fees, not taxpayers, financed the employee salaries.The New York Times - 10h -
Shares of Hims & Hers tumble 26% after FDA says semaglutide is no longer in shortage
Shares of Hims & Hers tumble 26% after FDA says semaglutide is no longer in shortageCNBC - 6h